CNRWX
Price
$22.34
Change
-$0.96 (-4.12%)
Updated
Apr 3 closing price
Net Assets
354.83M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

CNRWX vs GFACX

Header iconCNRWX vs GFACX Comparison
Open Charts CNRWX vs GFACXBanner chart's image
City National Rochdale US Cor Eq N
Price$22.34
Change-$0.96 (-4.12%)
VolumeN/A
Net Assets354.83M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
CNRWX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNRWX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNRWX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. CNRWX (355M). CNRWX pays higher dividends than GFACX: CNRWX (0.02) vs GFACX (0.00). CNRWX was incepted earlier than GFACX: CNRWX (12 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than CNRWX (1.07). GFACX is a more actively managed with annual turnover of: 25.00 vs. CNRWX (20.00). CNRWX has a lower initial minimum investment than GFACX: CNRWX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. CNRWX (-8.11). GFACX return over 5 years is better than : 59.73 vs. CNRWX (50.27).
CNRWXGFACXCNRWX / GFACX
Total Expense Ratio1.071.3679%
Annual Report Gross Expense Ratio1.071.3679%
Fund Existence12 years24 years-
Gain YTD-3.400-5.00368%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets355M280B0%
Annual Yield % from dividends0.020.00-
Returns for 1 year-8.11-1.75463%
Returns for 3 years-9.210.63-1,459%
Returns for 5 years50.2759.7384%
Returns for 10 years78.0444.46176%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences